NCT06665230View on ClinicalTrials.gov

A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005)

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 20, 2023

Primary Completion Date

November 20, 2023

Study Completion Date

November 20, 2023

Conditions
HealthyNarcolepsy
Interventions
DRUG

MK-6552

Oral administration

DRUG

Modafinil

Oral administration

Trial Locations (1)

37920

Alliance for Multispecialty Research, LLC (Site 0001), Knoxville

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06665230 - A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005) | Biotech Hunter | Biotech Hunter